Lupin gets FDA nod for generic Prozac
Lupin has received the Food and Drug Administration’s blessing for its generic Prozac (fluoxetine tablets), in a 60-mg dosage strength.
It is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa, and panic disorder, with or without agoraphobia.
Fluoxetine tablets, 60-mg, had a market value of approximately $42.5 million, according to December 2018 IQVIA data.
No comments found